IDEXX LABORATORIES INC /DE Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate
IDEXX LABORATORIES INC /DE (IDXX) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate of 33.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate · last filed 2026-02-20
- IDEXX LABORATORIES INC /DE share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for the quarter ending 2025-03-31 was 33.00%, a 3.13% increase year-over-year.
- IDEXX LABORATORIES INC /DE share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for the quarter ending 2024-03-31 was 32.00%, a 0.00% change year-over-year.
- IDEXX LABORATORIES INC /DE share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for the quarter ending 2023-03-31 was 32.00%, a 6.67% increase year-over-year.
- IDEXX LABORATORIES INC /DE share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for the quarter ending 2022-03-31 was 30.00%, a 3.23% decline year-over-year.
- IDEXX LABORATORIES INC /DE share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for fiscal 2025 was 33.00%, a 3.13% increase from fiscal 2024.
- IDEXX LABORATORIES INC /DE share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for fiscal 2024 was 32.00%, a 0.00% change from fiscal 2023.
- IDEXX LABORATORIES INC /DE share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for fiscal 2023 was 32.00%, a 6.67% increase from fiscal 2022.
- IDEXX LABORATORIES INC /DE share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for fiscal 2022 was 30.00%, a 0.00% change from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate 12 month |
|---|---|---|---|---|
| 2025-12-31 | 33.00% 10-K · filed 2026-02-20 | |||
| 2025-09-30 | 33.00% 10-Q · filed 2025-11-03 | |||
| 2025-06-30 | 33.00% 10-Q · filed 2025-08-04 | |||
| 2025-03-31 | 33.00% 10-Q · filed 2025-05-01 | |||
| 2024-12-31 | 32.00% 10-K · filed 2026-02-20 | |||
| 2024-09-30 | 32.00% 10-Q · filed 2025-11-03 | |||
| 2024-06-30 | 32.00% 10-Q · filed 2025-08-04 | |||
| 2024-03-31 | 32.00% 10-Q · filed 2025-05-01 | |||
| 2023-12-31 | 32.00% 10-K · filed 2026-02-20 | |||
| 2023-09-30 | 32.00% 10-Q · filed 2024-10-31 | |||
| 2023-06-30 | 32.00% 10-Q · filed 2024-08-06 | |||
| 2023-03-31 | 32.00% 10-Q · filed 2024-05-01 | |||
| 2022-12-31 | 30.00% 10-K · filed 2025-02-21 | |||
| 2022-09-30 | 30.00% 10-Q · filed 2023-11-01 | |||
| 2022-06-30 | 30.00% 10-Q · filed 2023-08-01 | |||
| 2022-03-31 | 30.00% 10-Q · filed 2023-05-02 | |||
| 2021-12-31 | 30.00% 10-K · filed 2024-02-22 | |||
| 2021-09-30 | 30.00% 10-Q · filed 2022-11-01 | |||
| 2021-06-30 | 31.00% 10-Q · filed 2022-08-02 | |||
| 2021-03-31 | 31.00% 10-Q · filed 2022-05-04 | |||
| 2020-12-31 | 27.00% 10-K · filed 2023-02-16 | |||
| 2020-09-30 | 27.00% 10-Q · filed 2021-11-02 | |||
| 2020-06-30 | 27.00% 10-Q · filed 2021-07-30 | |||
| 2020-03-31 | 27.00% 10-Q · filed 2021-05-04 | |||
| 2019-12-31 | 26.00% 10-K · filed 2022-02-16 | |||
| 2019-09-30 | 26.00% 10-Q · filed 2020-10-29 | |||
| 2019-06-30 | 26.00% 10-Q · filed 2020-07-31 | |||
| 2019-03-31 | 26.00% 10-Q · filed 2020-04-30 | |||
| 2018-12-31 | 24.00% 10-K · filed 2021-02-12 | |||
| 2018-09-30 | 24.00% 10-Q · filed 2019-10-31 | |||
| 2018-06-30 | 24.00% 10-Q · filed 2019-08-01 | |||
| 2018-03-31 | 24.00% 10-Q · filed 2019-05-01 | |||
| 2017-12-31 | 26.00% 10-K · filed 2020-02-14 | |||
| 2017-09-30 | 26.00% 10-Q · filed 2018-11-01 | |||
| 2017-06-30 | 26.00% 10-Q · filed 2018-08-01 | |||
| 2017-03-31 | 26.00% 10-Q · filed 2018-05-04 | |||
| 2016-12-31 | 25.00% 10-K · filed 2019-02-15 | |||
| 2016-09-30 | 25.00% 10-Q · filed 2017-10-31 | |||
| 2016-06-30 | 25.00% 10-Q · filed 2017-08-01 | |||
| 2016-03-31 | 25.00% 10-Q · filed 2017-04-28 | |||
| 2015-12-31 | 23.00% 10-K · filed 2018-02-16 | |||
| 2015-09-30 | 23.00% 10-Q · filed 2016-11-01 | |||
| 2015-06-30 | 23.00% 10-Q · filed 2016-08-02 | |||
| 2015-03-31 | 23.00% 10-Q · filed 2016-04-29 | |||
| 2014-12-31 | 28.00% 10-K · filed 2017-02-17 | |||
| 2014-09-30 | 28.00% 10-Q · filed 2015-10-28 | |||
| 2014-06-30 | 28.00% 10-Q · filed 2015-07-30 | |||
| 2014-03-31 | 28.00% 10-Q · filed 2015-04-28 | |||
| 2013-12-31 | 32.00% 10-K · filed 2016-02-17 | |||
| 2013-09-30 | 33.00% 10-Q · filed 2014-10-24 | |||
| 2013-06-30 | 33.00% 10-Q · filed 2014-07-25 | |||
| 2013-03-31 | 33.00% 10-Q · filed 2014-04-25 | |||
| 2012-12-31 | 34.00% 10-K · filed 2015-02-17 | |||
| 2012-09-30 | 34.00% 10-Q · filed 2013-10-22 | |||
| 2012-06-30 | 34.00% 10-Q · filed 2013-07-23 | |||
| 2012-03-31 | 34.00% 10-Q · filed 2013-04-23 | |||
| 2011-12-31 | 33.00% 10-K · filed 2014-02-18 | |||
| 2011-09-30 | 33.00% 10-Q · filed 2012-10-19 | |||
| 2011-06-30 | 33.00% 10-Q · filed 2012-07-20 | |||
| 2011-03-31 | 33.00% 10-Q · filed 2012-04-20 | |||
| 2010-12-31 | 31.00% 10-K · filed 2013-02-19 | |||
| 2010-09-30 | 31.00% 10-Q · filed 2011-10-21 | |||
| 2009-12-31 | 31.00% 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |